A team of University of Miami Miller School of Medicine researchers has uncovered the secret behind a type of skin made from live human cells that stimulates healing of venous leg and diabetic foot ulcers. The FDA-approved Apligraf, which is marketed by Organogenesis, Inc., does not take to the wound as a graft would. Instead, it disappears from the wound within a week or two, yet it still triggers healing.
Already renowned for her work in hair and nail diseases, Antonella Tosti, M.D., a professor in the Department of Dermatology and Cutaneous Surgery at the University of Miami Miller School of Medicine, has been awarded the first Fredric Brandt Endowed Professorship.
Following the recent Zika outbreak in Miami-Dade County, a multidisciplinary team of physicians with the University of Miami Health System and Miller School of Medicine published a case study January 11 in The New England Journal of Medicine, describing in detail the nation’s first locally transmitted case of Zika.
Even after years of careful research pointed investigators toward a novel pathway involved in wound healing, Marjana Tomic-Canic, Ph.D., and her team were still surprised. The specific molecule and the potential scope of applications to other autoimmune and inflammatory processes beyond the skin were both unexpected.
Greater student-teacher interaction, self-paced learning and improved educational outcomes are among the benefits of the innovative ’Cane Academy program at the University of Miami Miller School of Medicine, according to faculty members who have integrated new concepts into their courses.